Evidence map›Paper›PMID 31277410›Full record

ReviewViruses2019

Progress on the Prevention and Treatment of Hantavirus Disease.

Rebecca L Brocato, Jay W Hooper

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Hantavirus stability and inactivation.PLoS neglected tropical diseases · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Review
  17. Article
  18. Recovering ImmunogenicVaccines · 2025
    Article
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rebecca L BrocatoVirology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.ORCID 0000-0003-4377-0710
Jay W HooperVirology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Jay.W.Hooper.civ@mail.mil.
United States Army Medical Research Institute of Infectious Diseases · US

Funding

NIAID NIH HHS R01AI32313
6 · The paper itself

Abstract

Hantaviruses, members of the order

Indexed as

Adrenal Cortex HormonesAmidesAnimalsAntiviral AgentsClinical Trials as TopicHantavirus InfectionsHantavirus Pulmonary SyndromeHemorrhagic Fever with Renal SyndromeHumansImmunotherapyLactoferrinModels, AnimalNucleosidesOrthohantavirusPiperidinesPyrazines1-ribofuranosyl-3-ethynyl-(1,2,4)triazoleAdrenal Cortex HormonesAmidesAntiviral AgentsfavipiravirLactoferrinNucleosidesPiperidinesPyrazinesQuinazolinesRecombinant ProteinsRibavirinTriazolesVaccines, SyntheticvandetanibViral Vaccinesantiviralhantavirushantavirus pulmonary syndromehemorrhagic fever with renal syndromevaccine

Identifiers

PMID31277410
PMCPMC6669544
OpenAlexW2954783926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.